Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
603313.SS Stock Summary
Top 10 Correlated ETFs
603313.SS
In the News
603313.SS Financial details
Company Rating
Neutral
Market Cap
5.4B
Income
54.44M
Revenue
7.66B
Book val./share
6.43
Cash/share
1.02
Dividend
-
Dividend %
-
Employees
7.51K
Optionable
No
Shortable
Yes
Earnings
27 Apr 2024
P/E
104.87
Forward P/E
8.3
PEG
-8.89
P/S
0.86
P/B
1.83
P/C
9.12
P/FCF
122.19
Quick Ratio
0.54
Current Ratio
0.93
Debt / Equity
1.24
LT Debt / Equity
0.48
-
-
EPS (TTM)
0.1
EPS next Y
1.12
EPS next Q
-
EPS this Y
-116.07%
EPS next Y
1006.15%
EPS next 5Y
1006.15%
EPS last 5Y
-27.84%
Revenue last 5Y
21.33%
Revenue Q/Q
11.2%
EPS Q/Q
-81.88%
-
-
-
-
SMA20
11.11%
SMA50
-9.09%
SMA100
-9.09%
Inst Own
-
Inst Trans
-
ROA
1%
ROE
2%
ROC
0.02%
Gross Margin
36%
Oper. Margin
1%
Profit Margin
1%
Payout
255%
Shs Outstand
570.59M
Shs Float
239.99M
-
-
-
-
Target Price
-
52W Range
7.73-12.29
52W High
-22.5%
52W Low
+32.86%
RSI
43
Rel Volume
0.64
Avg Volume
6.08M
Volume
3.89M
Perf Week
-5.58%
Perf Month
15.82%
Perf Quarter
-
Perf Half Y
-21.39%
-
-
-
-
Beta
1.164
-
-
Volatility
0.17%, 0.34%
Prev Close
-0.21%
Price
9.3
Change
-1.9%
603313.SS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 7.56 | 9.31 | 19.15 | 16.84 | 17.45 | |
Net income per share | 0.46 | 0.91 | 1.11 | -0.56 | 0.09 | |
Operating cash flow per share | 0.43 | 0.32 | 1.71 | 0.14 | 1.23 | |
Free cash flow per share | -0.6 | -1.59 | -0.98 | -0.98 | -0.14 | |
Cash per share | 2.51 | 1.8 | 3.25 | 2.18 | 1.26 | |
Book value per share | 4.6 | 5.67 | 10.43 | 6.01 | 6.48 | |
Tangible book value per share | 4.2 | 5.19 | 9.36 | 5.12 | 5.66 | |
Share holders equity per share | 4.6 | 5.67 | 10.43 | 6.01 | 6.48 | |
Interest debt per share | 2.64 | 3.7 | 5.92 | 8.69 | 9.23 | |
Market cap | 5.25B | 6.69B | 8.51B | 8.37B | 4.87B | |
Enterprise value | 5.23B | 7.36B | 9.37B | 11.43B | 8.37B | |
P/E ratio | 28.21 | 17.89 | 22.47 | -31.03 | 117.78 | |
Price to sales ratio | 1.72 | 1.74 | 1.3 | 1.03 | 0.61 | |
POCF ratio | 29.98 | 51.5 | 14.6 | 123.19 | 8.62 | |
PFCF ratio | -21.55 | -10.22 | -25.55 | -17.75 | -74.17 | |
P/B Ratio | 2.83 | 2.86 | 2.39 | 2.88 | 1.64 | |
PTB ratio | 2.83 | 2.86 | 2.39 | 2.88 | 1.64 | |
EV to sales | 1.71 | 1.92 | 1.44 | 1.4 | 1.04 | |
Enterprise value over EBITDA | 15.36 | 11.28 | 13.33 | 32.19 | 10.65 | |
EV to operating cash flow | 29.85 | 56.67 | 16.09 | 168.3 | 14.81 | |
EV to free cash flow | -21.45 | -11.24 | -28.16 | -24.24 | -127.5 | |
Earnings yield | 0.04 | 0.06 | 0.04 | -0.03 | 0.01 | |
Free cash flow yield | -0.05 | -0.1 | -0.04 | -0.06 | -0.01 | |
Debt to equity | 0.56 | 0.63 | 0.54 | 1.4 | 1.36 | |
Debt to assets | 0.31 | 0.32 | 0.27 | 0.44 | 0.45 | |
Net debt to EBITDA | -0.07 | 1.03 | 1.23 | 8.63 | 4.46 | |
Current ratio | 1.89 | 1.29 | 1.43 | 1.06 | 0.99 | |
Interest coverage | 9 | 11.41 | 6.42 | -0.04 | 1.88 | |
Income quality | 0.89 | 0.33 | 1.4 | -0.25 | 10.88 | |
Dividend Yield | 0 | 0.02 | 0.01 | 0.03 | 0.03 | |
Payout ratio | 0.12 | 0.35 | 0.19 | -0.96 | 3.28 | |
Sales general and administrative to revenue | 0.03 | 0.03 | 0.04 | 0.04 | 0.03 | |
Research and developement to revenue | 0.03 | 0.03 | 0.02 | 0.02 | 0.01 | |
Intangibles to total assets | 0.06 | 0.06 | 0.07 | 0.06 | 0.05 | |
Capex to operating cash flow | -2.39 | -6.04 | -1.57 | -7.94 | -1.12 | |
Capex to revenue | -0.14 | -0.2 | -0.14 | -0.07 | -0.08 | |
Capex to depreciation | -8.02 | -10.19 | -6.88 | -1.5 | -1.42 | |
Stock based compensation to revenue | 0 | 0 | 0.01 | 0 | 0 | |
Graham number | 6.91 | 10.76 | 16.14 | 8.69 | 3.62 | |
ROIC | 0.07 | 0.1 | 0.07 | 0 | 0.03 | |
Return on tangible assets | 0.06 | 0.09 | 0.06 | -0.03 | 0 | |
Graham Net | 0.5 | -0.91 | -1.99 | -6.55 | -7.44 | |
Working capital | 990.13M | 589.84M | 1.17B | 232.93M | -22.33M | |
Tangible asset value | 1.7B | 2.13B | 3.19B | 2.48B | 2.6B | |
Net current asset value | 611.68M | 392.4M | 467.24M | -1.78B | -2.11B | |
Invested capital | 0.56 | 0.63 | 0.54 | 1.4 | 1.36 | |
Average receivables | 567.24M | 818.56M | 1.09B | 1.28B | 1.44B | |
Average payables | 307.94M | 417.46M | 718.75M | 1.22B | 1.4B | |
Average inventory | 346.87M | 554.94M | 1.05B | 1.65B | 1.83B | |
Days sales outstanding | 79.55 | 92.64 | 67.73 | 60.63 | 69.93 | |
Days payables outstanding | 58.39 | 79.58 | 78.99 | 95 | 84.64 | |
Days of inventory on hand | 64.87 | 117.23 | 115.69 | 121.57 | 114.19 | |
Receivables turnover | 4.59 | 3.94 | 5.39 | 6.02 | 5.22 | |
Payables turnover | 6.25 | 4.59 | 4.62 | 3.84 | 4.31 | |
Inventory turnover | 5.63 | 3.11 | 3.16 | 3 | 3.2 | |
ROE | 0.1 | 0.16 | 0.11 | -0.09 | 0.01 | |
Capex per share | -1.04 | -1.9 | -2.68 | -1.12 | -1.37 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 3.99 | 4.24 | 3.04 | 4.56 | 4.36 | |
Net income per share | 0.03 | -0.13 | 0.03 | 0.19 | 0.03 | |
Operating cash flow per share | 0.03 | -0.13 | 0.03 | 0.56 | 0.79 | |
Free cash flow per share | -0.3 | -0.45 | -0.06 | 0.27 | 0.38 | |
Cash per share | 1.25 | 1.26 | 0.93 | 1.34 | 1.02 | |
Book value per share | 6.05 | 6.48 | 5.37 | 7.54 | 6.43 | |
Tangible book value per share | 5.28 | 5.66 | 4.69 | 6.63 | 5.66 | |
Share holders equity per share | 6.05 | 6.48 | 5.37 | 7.54 | 6.43 | |
Interest debt per share | 9.16 | 8.97 | 6.9 | 9.47 | 8.11 | |
Market cap | 4.85B | 4.87B | 5.98B | 4.18B | 5.74B | |
Enterprise value | 8.76B | 8.37B | 9.28B | 7.54B | 9.15B | |
P/E ratio | 80.29 | -20.82 | 89.08 | 12.94 | 93.72 | |
Price to sales ratio | 2.44 | 2.5 | 3.52 | 2.2 | 2.71 | |
POCF ratio | 321.16 | -83.28 | 356.33 | 17.87 | 15.07 | |
PFCF ratio | -32.67 | -23.62 | -164.93 | 37.56 | 31.07 | |
P/B Ratio | 1.61 | 1.64 | 1.99 | 1.33 | 1.84 | |
PTB ratio | 1.61 | 1.64 | 1.99 | 1.33 | 1.84 | |
EV to sales | 4.41 | 4.3 | 5.46 | 3.96 | 4.32 | |
Enterprise value over EBITDA | 103.12 | 1.38K | 111.66 | 48.58 | 72.22 | |
EV to operating cash flow | 580.45 | -143.16 | 553.4 | 32.21 | 24.01 | |
EV to free cash flow | -59.05 | -40.6 | -256.15 | 67.69 | 49.5 | |
Earnings yield | 0 | -0.01 | 0 | 0.02 | 0 | |
Free cash flow yield | -0.03 | -0.04 | -0.01 | 0.03 | 0.03 | |
Debt to equity | 1.5 | 1.36 | 1.27 | 1.24 | 1.24 | |
Debt to assets | 0.48 | 0.45 | 0.41 | 0.41 | 0.4 | |
Net debt to EBITDA | 46.06 | 577.53 | 39.76 | 21.62 | 26.89 | |
Current ratio | 0.99 | 0.99 | 0.99 | 0.98 | 0.93 | |
Interest coverage | 1.21 | -0.85 | 0.41 | 1.72 | 0.43 | |
Income quality | 1 | 1 | 1 | 2.89 | 24.88 | |
Dividend Yield | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
Payout ratio | 2.23 | -0.67 | 2.51 | 0.5 | 1.12 | |
Sales general and administrative to revenue | 0.16 | -0.1 | 0.07 | -0.01 | 0.14 | |
Research and developement to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | |
Intangibles to total assets | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | |
Capex to operating cash flow | -10.83 | 2.53 | -3.16 | -0.52 | -0.52 | |
Capex to revenue | -0.08 | -0.08 | -0.03 | -0.06 | -0.09 | |
Capex to depreciation | -1.25 | -1.13 | -0.37 | -0.86 | 0.83 | |
Stock based compensation to revenue | -0.12 | -0.15 | 0 | -0.08 | 0 | |
Graham number | 2.03 | 4.31 | 1.9 | 5.74 | 2.14 | |
ROIC | 0.01 | -0.01 | 0 | 0.01 | 0 | |
Return on tangible assets | 0 | -0.01 | 0 | 0.01 | 0 | |
Graham Net | -7.12 | -7.44 | -6.31 | -8.73 | -7.86 | |
Working capital | -25.36M | -22.33M | -36.63M | -79.12M | -299.99M | |
Tangible asset value | 2.62B | 2.6B | 2.62B | 2.77B | 2.75B | |
Net current asset value | -2.14B | -2.11B | -2.22B | -2.34B | -2.49B | |
Invested capital | 1.5 | 1.36 | 1.27 | 1.24 | 1.24 | |
Average receivables | 1.59B | 1.58B | 1.56B | 1.66B | 1.8B | |
Average payables | 1.27B | 1.29B | 1.28B | 1.3B | 1.4B | |
Average inventory | 1.94B | 1.82B | 1.73B | 1.69B | 1.63B | |
Days sales outstanding | 73.23 | 70.92 | 83.72 | 82.77 | 78.87 | |
Days payables outstanding | 85.42 | 91.6 | 105.01 | 97.98 | 100.19 | |
Days of inventory on hand | 125.68 | 123.59 | 143.85 | 120.95 | 110.02 | |
Receivables turnover | 1.23 | 1.27 | 1.08 | 1.09 | 1.14 | |
Payables turnover | 1.05 | 0.98 | 0.86 | 0.92 | 0.9 | |
Inventory turnover | 0.72 | 0.73 | 0.63 | 0.74 | 0.82 | |
ROE | 0.01 | -0.02 | 0.01 | 0.03 | 0 | |
Capex per share | -0.33 | -0.32 | -0.09 | -0.29 | -0.4 |
603313.SS Frequently Asked Questions
What is Healthcare Co., Ltd. stock symbol ?
Healthcare Co., Ltd. is a CN stock and trading under the symbol 603313.SS
What is Healthcare Co., Ltd. stock quote today ?
Healthcare Co., Ltd. stock price is $9.3 today.
Is Healthcare Co., Ltd. stock public?
Yes, Healthcare Co., Ltd. is a publicly traded company.